Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
New Hope for HIV Eradication
New Synthetic Proteins Block HIV
Additional Funding Awarded for Adherence Breathalyzer
A New Avenue Opens for Treating KS, CMV and Other Herpes Diseases
New Life for Treatment Interruptions?
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

June 18, 2009

Interleukin-10 Blunts HIV Infection and Disease Progression

People who are genetically predisposed to have high levels of a protein called interleukin-10 (IL-10), which helps regulate the immune system, may have a lower risk of becoming infected with HIV, or slower disease progression if they’re already infected with the virus, according to a study published online June 17 in The Journal of Infectious Diseases.

Interleukins, also known as cytokines, enable immune system cells to communicate with each other and can provoke a wide array of effects in the body. One much-studied cytokine, IL-2, spurs the production of CD4 cells, while other cytokines blunt immune responses. A few small studies have provided conflicting evidence that higher natural levels of the cytokine IL-10 may contribute to slower HIV disease progression.

To explore the impact of IL-10 production on HIV, Dshanta Naicker, PhD, from the University of KwaZulu-Natal, in Durban, South Africa, and her colleagues examined blood samples and medical records from 259 HIV-positive and HIV-negative women enrolled in the Centre for the AIDS Programme of Research in South Africa (CAPRISA) acute infection cohort study. During the course of that study, 64 women were infected with HIV.

Women who were genetically more likely to have high levels of IL-10 turned out to have a much lower risk of becoming infected with HIV than women with a predisposition to have very low levels of IL-10.

Results involving women who were infected with HIV were less clear. During the acute early phase of infection, women more likely to have high IL-10 levels had higher viral loads than women more likely to have low IL-10 levels. This trend, however, completely reversed once a woman entered the chronic stage of infection. At this point, a predisposition for higher IL-10 production was associated with lower viral loads, whereas a predisposition for lower IL-10 production translated into higher viral loads.

Naicker and her colleagues conclude that a genetic predisposition for higher IL-10 production might protect against HIV infection, and that over time, it might also be associated with slower HIV disease progression. They are encouraging further research, however, to confirm this finding.

Search: Interleukin-10, IL-10, cytokine, disease progression, transmission, infection, Dshanta Naicker


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy